We utilized the A549 lung cancer model, in which ALYREF has been shown to facilitate tumor proliferation through m5C‐dependent mechanisms.[14] A DIC model was established in A549 tumor‐bearing mice (Figure S8c, Supporting Information). Here, ALYREF is linked to lung carcinoma.